Search

Your search keyword '"Basch, Ethan"' showing total 1,616 results

Search Constraints

Start Over You searched for: Author "Basch, Ethan" Remove constraint Author: "Basch, Ethan"
1,616 results on '"Basch, Ethan"'

Search Results

151. Additional file 1 of Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trial

152. Additional file 2 of Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trial

156. Effects of patient-reported outcome assessment order

158. Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

164. Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

165. Digital symptom monitoring with patient-reported outcomes in community oncology practices: A U.S. national cluster randomized trial.

166. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD)

168. Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

170. Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study

174. Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

183. PD03-12 LONG-TERM DECISIONAL REGRET FOR MINORITY MEN DIAGNOSED WITH PROSTATE CANCER: RESULTS FROM A MULTI-CENTERED RANDOMIZED CLINICAL TRIAL OF DECISION AID

185. Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 and COMET-2

186. Pediatric lymphoma patients in Malawi present with poor health‐related quality of life at diagnosis and improve throughout treatment and follow‐up across all Pediatric PROMIS‐25 domains

187. Reply by Authors

190. Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

191. A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

192. The missing voice of patients in drug-safety reporting

194. Development of the National Cancer Instituteʼs Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

197. A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer

199. Implementation of electronic patient-reported outcomes for symptom monitoring in a large multi-site community oncology practice.

Catalog

Books, media, physical & digital resources